Anzeige
Mehr »
Login
Dienstag, 08.10.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
EXPLOSIVES WACHSTUM voraus: URAN-AKTIEN vor dem großen Durchbruch – Hier jetzt ZUGREIFEN!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
422 Leser
Artikel bewerten:
(2)

Berkeley Frontier Fund Debuts; Aims to Give Back $25 Million to UC Berkeley

Built by alums alongside University leadership, Berkeley Frontier Fund is the official growth stage Berkeley VC fund, investing in highest-profile UC Berkeley-founded startups and donating back to University programs

BERKELEY, CA / ACCESSWIRE / May 5, 2022 / Berkeley Frontier Fund (BFF), the Berkeley venture capital fund focused on investing in the most successful and highest growth UC Berkeley-founded companies, is announcing its new fund, leading in turn to the largest possible donation back to University programs. The fund has already made its first four investments: AyarLabs, Databricks, Mammoth Biosciences, and Neurona Therapeutics.

Donations from the fund will be directly allocated by a donation committee in support of programs that benefit students across campus and help the university address the perennial challenge of lack of program funding. The fund will make its first $2.5 million contribution to UC Berkeley in Q4 of 2022. The Berkeley Frontier Fund has set an ambitious goal to return $25 million back to the University over the lifetime of the fund.

Berkeley Frontier Fund, Thursday, May 5, 2022, Press release picture

The fund is managed and advised by Berkeley alums. Richard Chan, formerly managing partner of Ironfire Ventures and MBA '04/BA '96, is leading the fund with support from members of the University's board of trustees, dean and department chairs as well as campus oversight from Rich Lyons, UC Berkeley's chief innovation and entrepreneurship officer.

"BFF aims to provide a meaningful and sustainable revenue source for Berkeley. We are pioneering a way for alumni to give back. From the fund's General Partners to the investors to the company founders, every stakeholder in BFF contributes to the cause," said Chan. "With our unique approach, BFF is acting as a conduit for UC Berkeley to benefit from all the entrepreneurship on campus. I envision this alumni-driven initiative to bring capital for labs, housing, equipment and more to help address the school's enduring challenges."

Why BFF now?

UC Berkeley is recognized as the world's No. 1 public university; however, it has been challenged financially for years. Today the University receives less than 13% of its operating budget from the state. In addition, Berkeley's endowment per student is approximately one-tenth of the endowment at private universities of similar stature.

Over the past 20 years, Berkeley entrepreneurs have created more than $500 billion in public and private market value. BFF was established with a mission to help Berkeley participate in that windfall.

"This extraordinary new Berkeley Frontier Fund is one of the most innovative ways for a public school to engage in the new age of entrepreneurship and is pioneering a new way for successful alumni to contribute back to Berkeley," said Lyons. "The incredible talent and opportunity within the UC Berkeley ecosystem gives the fund a broad range of options when it comes to investment."

One way the fund can help the University capture that capital is through investments in technology spin outs and inventions created in its labs. BFF has a contractual relationship with the University that allows it to partner with the University's IP office on rights; thus giving it investment access into companies utilizing this Berkeley IP.

While there are a number of Berkeley-focused venture funds currently working with University startups, the majority don't have any direct give-back to the university. "Berkeley Frontier Fund makes these direct contributions plus a one-of-a-kind front-loaded donation component. That means 5% of total fund commitments will be donated within the first year of operation, making BFF a standout amongst all other donation efforts," said Loraine Binion, treasurer at the UC Berkeley Foundation and a member of the BFF donation committee.

"To do well by doing good, we invite all UC Berkeley alumni to join us in this journey," concluded Chan.

For more information, visit berkeleyfrontier.com.

Images: here

About Berkeley Frontier Fund

Berkeley Frontier Fund (BFF) is a philanthropic VC fund and the official Berkeley Venture Fund. It is designed to become a meaningful and sustainable revenue source for UC Berkeley, the world's top-rated public university. The fund invests in the best growth-stage Berkeley startups and donates a substantial portion of total profits back to University departments and programs. Berkeley Frontier Fund management and advisors are all UC Berkeley alumni. The fund's stakeholders believe in a shared responsibility toward the University and its emerging entrepreneurs. For more information, visit berkeleyfrontier.com.

Media Contact
Erica Zeidenberg
Hot Tomato Marketing
925-518-8159
erica@hottomato.net

SOURCE: Berkeley Frontier Fund



View source version on accesswire.com:
https://www.accesswire.com/700215/Berkeley-Frontier-Fund-Debuts-Aims-to-Give-Back-25-Million-to-UC-Berkeley

© 2022 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.